norfloxacin has been researched along with Otitis Externa in 4 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Otitis Externa: Inflammation of the OUTER EAR including the external EAR CANAL, cartilages of the auricle (EAR CARTILAGE), and the TYMPANIC MEMBRANE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The research's goal is to design and formulate nano-structured cubosomes loaded with norfloxacin (NFX)formanagement of otitis externa." | 8.02 | Norfloxacin loaded nano-cubosomes for enhanced management of otitis externa: In vitro and in vivo evaluation. ( Abdelbary, AA; Al-Mahallawi, AM; El-Zahaby, SA, 2021) |
| "The research's goal is to design and formulate nano-structured cubosomes loaded with norfloxacin (NFX)formanagement of otitis externa." | 4.02 | Norfloxacin loaded nano-cubosomes for enhanced management of otitis externa: In vitro and in vivo evaluation. ( Abdelbary, AA; Al-Mahallawi, AM; El-Zahaby, SA, 2021) |
| "At the Eastern Section Meeting of the Triological Society January 26, 1990, Levinson et al reported outstanding success with ciprofloxacin in the treatment of malignant otitis externa." | 3.68 | The fluoroquinolones. ( Brody, T; Pensak, ML, 1991) |
| "Twelve elderly diabetic patients with Pseudomonas otitis externa malignum were successfully treated with norfloxacin as monotherapy for 2-5 weeks, using 400 mg b." | 3.68 | Otitis externa malignum. ( Sabbour, MS, 1991) |
| "Feline otitis externa is a dermatological disorder with a multifactorial complex etiology." | 1.62 | Otodectic and bacterial etiology of feline otitis externa in Tripoli, Libya. ( Altaeb, AA; Bennour, EM; Duro, EM; Ellraiss, OM; Elmishri, RA; Hiblu, MA; Karim, ES, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiblu, MA | 1 |
| Ellraiss, OM | 1 |
| Karim, ES | 1 |
| Elmishri, RA | 1 |
| Duro, EM | 1 |
| Altaeb, AA | 1 |
| Bennour, EM | 1 |
| Al-Mahallawi, AM | 1 |
| Abdelbary, AA | 1 |
| El-Zahaby, SA | 1 |
| Brody, T | 1 |
| Pensak, ML | 1 |
| Sabbour, MS | 1 |
4 other studies available for norfloxacin and Otitis Externa
| Article | Year |
|---|---|
Otodectic and bacterial etiology of feline otitis externa in Tripoli, Libya.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Female; Gentamicins; Libya; Male; Mite Infestati | 2021 |
Norfloxacin loaded nano-cubosomes for enhanced management of otitis externa: In vitro and in vivo evaluation.
Topics: Animals; Liquid Crystals; Nanoparticles; Norfloxacin; Otitis Externa; Particle Size; Poloxamer; Rabb | 2021 |
The fluoroquinolones.
Topics: Bacterial Infections; Ciprofloxacin; Humans; Norfloxacin; Otitis Externa | 1991 |
Otitis externa malignum.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Diabetes Complications; Female; Humans; Male; Norflo | 1991 |